Orion Portfolio Solutions’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Orion Portfolio Solutions’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,682	Closed	-$273K	–	1695
2023 Q2	$273K	Buy	2,682 +5	+0.2%	+$473	﹤0.01%	1438
2023 Q1	$243K	Buy	+2,677	New	+$157K	﹤0.01%	1423
2020 Q1	–	Sell	-8	Closed	-$2K	–	2397
2019 Q4	$2K	Buy	+8	New	+$1.46K	﹤0.01%	1576

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Orion Portfolio Solutions's RETA Position: Q3 2023 in Review

Orion Portfolio Solutions sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 2,682 shares — an estimated $273K sold.

Orion Portfolio Solutions first reported a position in RETA in Q4 2019 and held it in 3 quarters. The position peaked at $273K in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Orion Portfolio Solutions reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Orion Portfolio Solutions sold 2,682 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $273K.
Orion Portfolio Solutions first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and held it in 3 quarters.
Orion Portfolio Solutions's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $273K in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Orion Portfolio Solutions's 13F filing for Q3 2023, filed 1 Nov 2023.